Onegen Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.26 M
as on 16-11-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -8.44%
(FY 2023)
- Profit -53.73%
(FY 2023)
- Ebitda -53.02%
(FY 2023)
- Net Worth -137.78%
(FY 2023)
- Total Assets 10.94%
(FY 2023)
About Onegen Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.26 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh, Praveen, Dambigan Ravisankar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290KA2019PTC129270
- Company No.
129270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Onegen Healthcare Private Limited offer?
Onegen Healthcare Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibiotic Injection, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Antifungal Injection, Tablet & Syrup, Osteoporosis Medications.
Who are the key members and board of directors at Onegen Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh  | Director | 01-Aug-2023 | Current |
| Praveen | Director | 01-Aug-2023 | Current |
| Dambigan Ravisankar | Director | 04-Nov-2019 | Current |
| Dambigam Khanna | Director | 04-Nov-2019 | Current |
Financial Performance of Onegen Healthcare.
Onegen Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.44% decrease. The company also saw a substantial fall in profitability, with a 53.73% decrease in profit. The company's net worth observed a substantial decline by a decrease of 137.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onegen Healthcare?
In 2023, Onegen Healthcare had a public holding of 43.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Onegen Healthcare?
Unlock and access historical data on people associated with Onegen Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onegen Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onegen Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
